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Background: The exon junction complex (EJC) is a dynamic multi-protein complex deposited onto nuclear spliced
mRNAs upstream of exon-exon junctions. The four core proteins, eIF4A3, Magoh, Y14 and MLN51, are stably bound
to mRNAs during their lifecycle, serving as a binding platform for other nuclear and cytoplasmic proteins. Recent
evidence has shown that the EJC is involved in the splicing regulation of some specific events in both Drosophila
and mammalian cells.
Results: Here, we show that knockdown of EJC core proteins causes widespread alternative splicing changes in
mammalian cells. These splicing changes are specific to EJC core proteins, as knockdown of eIF4A3, Y14 and MLN51
shows similar splicing changes, and are different from knockdown of other splicing factors. The splicing changes
can be rescued by a siRNA-resistant form of eIF4A3, indicating an involvement of EJC core proteins in regulating
alternative splicing. Finally, we find that the splicing changes are linked with RNA polymerase II elongation rates.
Conclusion: Taken together, this study reveals that the coupling between EJC proteins and splicing is broader than
previously suspected, and that a possible link exists between mRNP assembly and splice site recognition.Background
Gene expression in eukaryotes is a highly regulated
multi-step process. In the cell, nascent transcripts asso-
ciate with various proteins to form ribonucleoprotein
(RNP) particles. The composition of RNPs, specific of
each transcript, changes during the successive stages of
mRNA life cycle to orchestrate post-transcriptional
regulation [1]. The exon junction complex (EJC) plays a
central role in connecting different post-transcriptional
events [2,3].
The EJC is a multi-protein complex which consists of
four core proteins (eIF4A3, Magoh, Y14 and MLN51),
serving as a binding platform for other nuclear and cyto-
plasmic proteins [4]. The EJC is deposited onto mRNAs
during splicing 24 nucleotides (nt) upstream of exon-
exon junction in a sequence-independent manner [5-8].
The assembly of EJC is tightly coupled to the splicing
process [9,10]. The splicing factor CWC22 participates
in the initial step of EJC assembly by recruiting eIF4A3
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unless otherwise stated.where eIF4A3 binds the Magoh/Y14 heterodimer, and
the full EJC core is formed when MLN51 joins the com-
plex at the late stage of splicing [10]. Studies of EJC
binding sites in mammalian cells have revealed that EJC
are differentially loaded onto different exon junctions of
the same mRNA, both at its canonical binding sites
(-24 nt position) as well as non-canonical sites [7,8,13].
Up to now, however, the mechanism that regulates dif-
ferential deposition remains unknown.
Functionally, the EJC has been shown to play a role in
several post-splicing events, including mRNA transport
[14], translation [15-17] and surveillance by nonsense-
mediated mRNA decay (NMD) [18,19]. There are several
pathways that trigger NMD, and the best-described ex-
amples involve the EJC. Once deposited, the EJC recruits
Upf3b in the nucleus and Upf2 in the cytoplasm. When
a ribosome stalls at a premature termination codon
(PTC) more than 50 nt upstream of an EJC, Upf1 joins
the downstream EJC to form the surveillance complex,
and triggers translation inhibition and mRNA degrad-
ation [18,19]. NMD not only functions to prevent the
translation of aberrant mRNAs that arise from transcrip-
tion and splicing errors, but some alternative splicing (AS)
events can also exploit NMD to regulate their expressiontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wang et al. Genome Biology 2014, 15:551 Page 2 of 18
http://genomebiology.com/2014/15/12/551(AS-NMD) [20-22]. Around one-third of alternative
spliced mRNAs has been predicted to contain PTCs in the
open reading frame, and they are targets for NMD [23,24].
Notably, several splicing factors including SR and hnRNP
proteins utilise AS-NMD to auto-regulate their own tran-
script level through a negative feedback loop [21,25,26].
In addition, the EJC has been shown to be required for
the splicing of mapk pre-mRNA and other long intron-
containing pre-mRNAs in Drosophila [27,28], and two
recent studies revealed that EJC components contribute
to the splicing of weak intron 4 of the piwi transcript in
Drosophila [29,30]. In Xenopus, eIF4A3 is also required
for accurate splicing of ryanodine receptor pre-mRNA
[31]. In addition to constitutive splicing of introns, EJC
components are involved in the regulation of apoptotic
regulator Bcl-x alternative splicing in mammalian cells
[32]. However, in this case, the binding of EJC compo-
nents to the Bcl-x pre-mRNA is required but does not
follow the conventional mode of EJC core binding to
spliced mRNAs. To determine the extent by which EJC
may influence splicing in human cells, we investigated
the impact of the knockdown (KD) of EJC core compo-
nents on endogenous alternative splicing patterns in a
transcriptome-wide scale. Downregulation of EJC core
components causes global changes in alternative spli-
cing, as well as splicing of a subset of constitutive exons,
indicating that they are involved in general splice site
recognition. The splicing changes are specific to EJC
core proteins and require EJC core integrity. The effect
of EJC core components downregulation is compensated
by different drugs affecting RNA polymerase elongation
rate, strongly suggesting a link between mRNP assembly
and transcription.
Results
Transcriptomic analysis in EJC knockdown HeLa cells
To evaluate the effect of EJC on mRNA processing on a
global scale, we performed mRNA-seq experiments in
HeLa cells in which the EJC core protein eIF4A3, Y14
and MLN51 were independently depleted with specific
siRNA. In parallel, we performed mRNA-seq in HeLa
cells treated with Upf1 siRNA, a key regulator for the
NMD pathway. The knockdown (KD) efficiency for each
protein was confirmed by western blot and qPCR ana-
lysis (Additional file 1A and B). We can achieve 40% to
60% depletion for eIF4A3 protein, whereas 70% to 80%
of Y14, MLN and Upf1 proteins were depleted. Since
Magoh and Y14 act as a dimer, depletion of Y14 also
decreased Magoh protein level (Additional file 1A). Two
biological replicate experiments were performed, and
86% of the reads can be mapped to human genome as
unique reads (Additional files 1C and 2). In total, mRNA-
seq generated a combined 93.8, 64.2, 66.2, 73.1 and 47.7
million reads for KD of GFP, eIF4A3, Y14, MLN and Upf1,respectively (Additional file 2). The total numbers of reads
per gene are highly correlated between the two replicate
experiments (Additional file 1D).
We performed differential expression analysis using
the DEseq package [33]. As expected, each KD sample
showed a significant decrease in the expression of the
corresponding gene (Additional file 3). We chose a read
coverage of 10 (approximately RPKM = 30) as a cutoff to
filter genes with low expression levels. Correlation ana-
lysis showed that the expression changes among differ-
ent EJC component KDs are more correlated than that
between eIF4A3 KD and Upf1 KD (Additional file 1E).
DEseq identified 95 genes (1%) to be significantly chan-
ged in EJC KD samples compared with GFP control (ad-
justed P <0.05), with four genes consistently changed
among all three EJC KD conditions (Additional files 3
and 4A). The small number of overlapping genes is most
likely due to the incomplete KD, especially in the case of
eIF4A3. In addition, the EJC core proteins could have
functions outside EJC, and the number of genes that are
expected to change in all three different protein deple-
tion are low. Similarly, comparing genes that are signifi-
cantly changed in any of the EJC KD (EJC union) with
Upf1 KD showed five overlapping genes, all of which
were significantly increased (Additional file 4B). The
changes in expression in different KD conditions can be
validated by qPCR (Additional file 4C). Taken together,
significant changes in the expression of a small number
of genes can be detected by EJC downregulation.
Widespread splicing changes are identified in EJC
knockdown cells
We analysed the differential exon usage in response to
EJC proteins downregulation. To make a more compre-
hensive analysis, we used two different programs: MISO
(Mixture-of-Isoform) [34] and DiffSplice [35]. MISO es-
timates differential isoform expression level from the
known alternative splicing events. Since MISO does not
handle replicates, each replicate experiment was analysed
independently. DiffSplice, on the other hand, is an ab
initio method that assembles the genome without
known gene annotation and identifies alternative spli-
cing modules where alternative transcripts diverge. This
method allows the discovery of novel alternative splicing
events as well as previously known alternative splicing
events, and handles replicate experiments for sample
variations. When we considered cassette exons with
exon inclusion level significantly changed more than 0.1
(ΔΨ >0.1, 1 being the total abundance of all isoforms),
MISO identified 103 or 552 cassette exons in any of the
EJC KDs in both replicates (intersection of MISO repli-
cates) or any of the replicates (union of MISO repli-
cates), respectively (Figure 1A, Additional files 5A,B
and 6). DiffSplice identified 715 cassette exons that have
Figure 1 Identification and validation of splicing changes in EJC KD cells. (A) Venn diagrams showing the overlap between significant
splicing events (cassette exons) identified with MISO and DiffSplice (left panels), using a threshold of 0.1 for ΔΨ. Correlation between the ΔΨ
values predicted by MISO and DiffSplice are shown on the right, and Pearson’s correlation coefficient (r2) is indicated. (B,C) RT-PCR validation of
two alternative exons (B) and one constitutive exon (C) in EJC and Upf1 KD cells. MRPL3 is predicted to increase in exon skipping (ΔΨ >0.1) in EJC
KD whereas C20orf7 is predicted to increase in exon inclusion (ΔΨ <0.1) in EJC KD. KPNA1 is predicted to increase in exon skipping (ΔΨ >0.1) in
EJC KD. The quantification of triplicate experiments are shown below as mean ± SD. ***P <0.001, one-way ANOVA.
Wang et al. Genome Biology 2014, 15:551 Page 3 of 18
http://genomebiology.com/2014/15/12/551exon inclusion level changed more than 0.1 (ΔΨ >0.1)
in EJC KD (Additional files 5C and 7). Among those
cassette exons, 61 (9%) or 237 (30%) overlap with the
ones identified by MISO, if we select genes changed in
both or either MISO replicates, respectively (Figure 1A).
The discrepancy between the two methods is partially
due to the ability of DiffSplice to identify novel splicingevents that are not within the MISO database. However,
since DiffSplice does not assemble the genome accord-
ing to previously known junctions, it does not identify
some of the alternative events present in MISO. When
looking at the cassette exons identified by both pro-
grams, the predicted exon inclusion change between
MISO and DiffSplice is well correlated (Figure 1A). For
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or DiffSplice or both programs, and selected a mixture
of exons that are predicted to change in all EJC KD or in
some of the EJC KD conditions. We validated 27 over 38
predicted cassette exon changes by RT-PCR (Figure 1B,
1C, Additional files 8 and 9). The validation rate for both
programs are similar (77% for MISO and 80% for DiffS-
plice), and both programs may complement each other in
identifying alternative splicing targets from mRNAseq
data. Even though some of the alternative splicing changes
were not predicted in some of the KD conditions (such as
TPCN1), RT-PCR confirmed a significant splicing change
for all EJC protein KDs, whereas UPF1 KD did not show
the same splicing changes. Therefore, much more cassette
exon events might be affected than those predicted by
both programs.
Surprisingly, of the 715 cassette exon events identified
by DiffSplice, 102 exons have no previous annotation in
the genome as alternative exons. These could be novel,
un-annotated alternative exons. Given that 91 (89%)
showed an increase in exon skipping in EJC KD, most of
these exons are normally constitutive exons in HeLa cells
that are defectively spliced when EJC level was downregu-
lated, demonstrating an important splicing activation of
EJC on some splicing events (Figure 1C). Several of these
differential splicing events, such as the KPNA1 gene, can
be validated by RT-PCR (Figure 1C, Additional file 9B).
We decided to use the union of DiffSplice and the inter-
section of MISO replicates for further analysis (765 events,
Additional file 10), which consist of both constitutive and
alternative splicing events. Remarkably, a majority of cas-
sette exons (487/765, 64%) showed an increase in exon
skipping in EJC KD conditions, indicating that the EJC
often facilitate exon recognition under normal conditions.
In addition, MISO and DiffSplice identified changes in
alternative 5′ splice site (A5SS), alternative 3′ splice site
(A3SS) and intron retention (IR) (Additional files 6 and 7).
These events can also be validated by RT-PCR (9/10 were
validated) (Additional files 8 and 11). Interestingly, MISO
did not identify tandem alternative polyadenylation iso-
forms in any of the condition. Other splicing regulators
have been shown to regulate tandem 3′UTR cleavage and
processing by binding at the 3′UTR and blocking the ac-
cess of the processing machinery [36]. Since EJC rarely
binds 3′UTR, it seems that EJC does not influence alter-
native 3′ end processing and polyadenylation. Taken to-
gether, the mRNA-seq experiments detect splicing events
reliably and accurately in response to EJC protein down-
regulation, revealing the implication of EJC core proteins
in the regulation of multiple splicing events.
The splicing changes depend on EJC core integrity
A previous study showed that individual EJC compo-
nents seem to preferentially associate with the Bcl-x pre-mRNA to regulate its alternative splicing, probably inde-
pendently of EJC core integrity [32]. Therefore, we have
examined whether the EJC-dependent splicing events
identified in this study require EJC core. To this end, we
performed rescue experiments with a siRNA-resistant
form of FLAG-eIF4A3WT in the background of eIF4A3
KD cells. In parallel, we also transfected a mutant form
of eIF4A3, FLAG-eIF4A3Mut that does not form EJC
[10]. Comparing the effects of these two forms of
eIF4A3 on EJC-dependent splicing is an important con-
trol to test EJC core integrity even if we cannot com-
pletely exclude that the mutant form of eIF4A3 can
have some impact on alternative splicing independent
of the EJC assembly. Both proteins can be overexpressed
in HeLa cells at comparable levels whilst the endogenous
eIF4A3 proteins were downregulated (Figure 2A). To con-
trol whether FLAG-eIF4A3WT can be incorporated into
the EJC, we performed co-immunoprecipitation ex-
periments with anti-FLAG tag. As expected, all three
core proteins MLN51, Y14 and Magoh can be co-
immunoprecipitated with the FLAG-eIF4A3WT but
not with the mutant FLAG-eIF4A3Mut (Figure 2B).
Next, candidate splicing events were examined by RT-
PCR under these conditions (Figure 2C, Additional file
12). For example, eIF4A3 KD caused an increase in exon
skipping of the constitutive exon 11 of KPNA1. Overex-
pression of FLAG-eIF4A3WT significantly reduced the
changes in exon skipping in eIF4A3 KD samples com-
pared with control samples (Figure 2C). In contrast,
overexpression of FLAG-eIF4A3Mut did not signifi-
cantly reduce the changes in exon skipping in eIF4A3
KD samples (Figure 2C). Similar splicing patterns can be
observed for the alternative exon 4 of MRPL3 (Figure 2C).
In the case of C20orf7 exon 9, which increases in
exon inclusion in eIF4A3 KD, the overexpression of
FLAG-eIF4A3WT partially rescued the increased in
exon inclusion in eIF4A3 KD cells whereas the mutant
did not (Figure 2C). In addition, overexpression of the
FLAG-eIF4A3Mut alone has a slight dominant-negative
effect, even though it does not rescue the eIF4A3 KD
cells (Figure 2C). This could be explained by FLAG-
eIF4A3Mut competing with wild-type eIF4A3 and in
turn causing less assembled EJC on mRNAs. Together,
these results showed that EJC core integrity is important
to regulate specific alternative splicing events.
The splicing changes are not associated with differential
decay rates
The splicing changes we observed could be due to differ-
ential decay rates of different isoforms. In mammals,
around one-third of the alternative splicing are predicted
to contain PTCs and may be subjected to AS-NMD
[23,26]. Stop codons are considered as premature if they
lie more than 50 nt upstream of an EJC. Decrease in EJC
Figure 2 The splicing changes in EJC KD can be rescued by overexpression of siRNA-resistant eIF4A3. (A) Western blot showing the
expression level of siRNA-resistant FLAG-eIF4A3 (WT) and a mutant that does not form EJC (D401KE402R, Mut) in the background of control and
endogenous eIF4A3 KD condition. GAPDH is shown as a loading control. (B) Immunoprecipitation of FLAG-eIF4A3WT and FLAG-eIF4A3Mut in
control and eIF4A3 KD cells. One/15th of input was loaded, and the immunoprecipitated samples were blotted for EJC components. GAPDH is
used as a negative control. (C) RT-PCR of alternative splicing patterns in control and eIF4A3 KD cells with eIF4A3WT or Mut. Three representative
genes were selected, with one constitutive exon (KPNA1) and two alternative exons (MRPL3, ΔΨ >0; C20orf7, ΔΨ <0). The quantification of
triplicate experiments are shown below as mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001, one-way ANOVA.
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therefore indirectly increase the expression level of PTC-
containing alternative spliced isoforms. In this case, the al-
ternative splicing changes should also depend on Upf1 de-
pletion. MISO and DiffSplice identified 58 (MISO, union
of replicates) and 389 (DiffSplice) cassette exon changes in
Upf1 KD, and only five (8.6%, MISO) and 158 (40.6%,
DiffSplice) overlapped with EJC KD, indicating that an im-
portant proportion of the splicing changes identified with
EJC KD are independent of NMD (Additional file 5B,C).
Several splicing changes corresponding to Upf1 knock-
down only, or both EJC and Upf1, were validated(Additional file 11D). We also searched for NMD features
present in different isoforms for EJC-regulated genes.
Among all the EJC-dependent splicing events, 155/451
(34.4%) was predicted to have a PTC in one of the iso-
forms. Out of the 155 exons, 23 (14.8%) showed an in-
crease in total mRNA level (FC > 1.5) in EJC KDs,
indicating that they are likely AS-NMD targets. Out of
these, three are constitutive exons, and 10 are known to
be NMD targets. These data showed that most of the spli-
cing changes are not accompanied by changes in mRNA
degradation, and that the EJC and Upf1 may affect alterna-
tive splicing profiles in different ways.
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joins UPF proteins to function in NMD, including
SMG1, SMG5, SMG6 and SMG7 [19]. Among these,
SMG6 can interact with EJC [37] and is the catalytic
endonuclease that cleaves the PTC-containing mRNAs
[38,39]. If SMG6 is directly recruited by the EJC, some
mRNA isoforms could eventually be degraded by SMG6
leading to a possible change in splicing patterns. To this
end, we performed siRNA against SMG6, and checked
alternative splicing pattern by RT-PCR (Additional file
13A). We selected both EJC-dependent alternative and
constitutive exons, and KD of SMG6 or Upf1 showed
no splicing changes (Additional file 13A). Therefore,
the majority of alternative splicing changes we exam-
ined upon EJC KD are not linked to NMD.
The NMD pathway is not the only way to degrade
RNA. The apparent alternative splicing patterns may be
due to different stability of the isoforms. To test this
possibility, we next performed a mRNA decay assay to
measure mRNA levels when transcription was blocked
by Actinomycin D. Cells were collected at different time
points after adding the drugs, and the amount of alterna-
tive isoforms of several candidate genes were measured by
RT-qPCR (Additional file 13B,C and 14). The MYC gene
served as a positive control as it showed a rapid mRNA
decay rate as previously described [40], whereas the
negative control DNM2 showed no decay after 24 h
(Additional file 13B). We selected three candidate genes
MRPL3, HNRNPDL and PSMD2 to test our hypothesis.
No significant changes in mRNA decay rate can be seen
between control and eIF4A3 KD samples for the dif-
ferent isoforms (Additional file 13C). Therefore, the al-
ternative splicing changes does not seem to be due to
differential stability of the two isoforms.
EJC core downregulation does not significantly affect
splicing factors expression level
Several EJC peripheral factors, including ASAP and PSAP
complex components are bona fide splicing regulators
[41,42]. In addition, EJCs associate with several SR pro-
teins [7,8]. KD of EJC core components could prevent the
association of these splicing factors to certain transcripts,
causing changes in splice site choices. To test this, we
downregulated Acinus, SRSF1 and SRSF2 with specific
siRNAs in HeLa cells (Figure 3A). The EJC-dependent
splicing events we tested were not affected by any of these
splicing factors KD (Figure 3B and C, Additional files 9
and 11). This is true both for un-annotated cassette exons
such as KPNA1 and for alternative exons such as MRPL3
and C20orf7 when EJC KD promote exon skipping and
inclusion, respectively (Figure 3B and C). An exception
was the splicing changes in SRSF2 exon 3, where SRSF2
downregulation caused the opposite effect of EJC KD
(Additional file 9A). Another example is BCAR1 exon 5and 6, where KD of EJC caused a significant increase in
exon skipping, whereas KD of Acinus and SRSF1 caused
an opposite effect (Additional file 9B). Taken together,
most of the splicing changes we examined are specific to
the EJC core components, and are not caused by EJC-
associated splicing factors.
The changes in alternative splicing could also be due
to changes in expression of other general splicing regula-
tors, and indirectly cause splicing changes. To this end,
we examined the expression of several splicing regula-
tors from the mRNA-seq data. We chose genes with the
GO term mRNA processing and splicing regulation, and
none of these genes were significantly changed upon
EJC KD (Additional file 15). We also validated some
splicing factors by qPCR based on their fold changes.
Most of the genes were not significantly changed in all
three EJC component KDs, indicating that the majority
of the splicing changes we observed are most likely not
caused by changes in splicing regulator expressions
(Additional file 16). The exception is DDX47, which is
significantly changed in all KD conditions (Additional
file 16). DDX47 is a helicase involved in rRNA process-
ing and its function in pre-mRNA splicing is currently
unknown [43].
EJC regulates cassette exons with longer flanking introns
We next analysed whether the EJC-dependent cassette
exons have similar characteristics. We considered only
cassette exons flanked by constitutive exons, and any
exons with complex splicing patterns were excluded.
Altogether, we defined 451 EJC-dependent cassette
exons (293 exon ΔΨ >0, 65%; 158 exon ΔΨ <0, 35%). As
control, we used 991 random alternative cassette exons
without splicing changes in all EJC KD identified by
MISO. In addition, we analysed the 73 EJC-dependent
un-annotated cassette exons, and used 681 random
constitutive exons without changes in EJC KD as a
control.
First, we examined the intron length. In Drosophila, it
has been shown that the EJC components regulate the
splicing of long-intron containing pre-mRNAs, and EJC
KD reduced their expression more than short intron-
containing pre-mRNAs [27]. We performed the same
analysis with HeLa cell transcriptome data but found no
correlation between intron length and differential ex-
pression level in any KD conditions in human cells
(Additional file 17). We then analysed the introns flanking
the alternative exons for EJC-dependent exon inclusion
(ΔΨ >0.1, +), exon skipping (ΔΨ <0.1, −) and control
exons (Figure 4A). The EJC-dependent cassette exons
have significantly longer flanking introns on either side
compared with the EJC-independent cassette exons, how-
ever the lengths are not different between exon inclusion
and skipping events (Figure 4A). This is also true for the
Figure 3 EJC-dependent splicing changes are specific to EJC core protein. (A) Western blot (left) and qPCR (right) showing the KD efficiency
of EJC core proteins as well as EJC associated protein Acinus, and SR proteins SRSF1 and SRSF2. GAPDH is used as a control. (B,C) RT-PCR of
splicing patterns of representative constitutive exons (B) and alternative exons (C) in different KD conditions. The quantification of triplicate
experiments are shown below as mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001, one-way ANOVA.
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flanking introns compared with control (Figure 4B).
Therefore, it seems that in human, the EJC also prefe-
rentially regulates alternative cassette exons that are
flanked by longer introns.
We then analysed the exon length, splice site strength
and the number of splicing enhancers and silencers (ESE,
ESS, ISE, ISS) around the alternative and the flanking con-
stitutive exons (Additional file 18). We observed more
ESEs but less ISEs around the EJC-dependent alternative
exons and flanking introns and exons, but there were no
significant differences between EJC-dependent exon inclu-
sion and exon skipping events (Additional file 18C and D).
However, no specific ESEs were enriched (Additional file
19), indicating that ESE alone cannot predict whether anexon is EJC-dependent. When analysing the EJC-
dependent constitutive exons, no significant changes
can be seen in any of the features analysed (Additional
file 17G-L). Therefore, the EJC-dependent cassette exons
seem to be more heavily regulated through ESEs com-
pared with the control exons, but no other specific feature
can be correlated.
EJC does not regulate splicing by binding at different
positions of the exons
By integrating multiple independent genome-wide data
sets, RNA splicing map has been used to show the pos-
itional regulatory effect of protein-RNA interactions
[44]. For example, by combining Nova CLIP data and
splice-junction microarray data, the RNA splicing map
Figure 4 Characteristics of EJC-dependent exons. (A) Box plot of intron lengths for flanking introns, comparing EJC-dependent exon inclusion
(+), exon skipping (−) and exons without splicing changes (Ctr). The P value is calculated with Mann–Whitney-Wilcoxon Test, and is indicated.
(B) Box plot of intron lengths for flanking introns, comparing EJC-dependent constitutive exons (Con) and EJC-independent constitutive exons
(Ctr Con). (C) RNA splicing map showing the normalised eIF4A3 CLIP reads in the upstream exon, cassette exon and downstream exon, 100 nt
from the exon-intron border. EJC-dependent exon inclusion (+) are shown as red, exon skipping (−) are shown as blue, and control exons with
has no splicing changes are shown as grey. The CLIP reads were normalised to mRNA expression level and exon length, and the height of CLIP
reads at a position is the sum of all normalised CLIP reads at that position for each category of exons.
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the upstream intron and within the exon, and acts as an
enhancer when positioned at the downstream intron
[44,45]. Here, we combined the CLIP-seq data of eIF4A3
[7] with the EJC-dependent splicing events to produce
the RNA splicing map for EJC (Figure 4C). Since eIF4A3
binds mainly within the exon, we analysed the alterna-
tive exon as well as the flanking constitutive exon,
100 nt from either side of the exon/intron border. In the
control exons (grey), eIF4A3 showed a characteristic en-
richment of binding around −24 nt from the exon-intron
border, and less well-defined enrichment in the 5′ half of
the exon representing non-canonical peaks [7] (Figure 4C).
Of note is that the CLIP signal is generally lower foralternative exons than for constitutive exons. For the EJC-
dependent exon inclusion (red) and exon skipping (blue),
the CLIP binding was similar to the control exons, with
enrichment at both canonical and non-canonical positions
(Figure 4C). We also generated RNA maps for EJC-
dependent included constitutive (or un-annotated alterna-
tive) exons compared with control constitutive exons
(Additional file 20A). The binding patterns were similar
between control and EJC-dependent exons. It has been
shown that EJC proteins bind the intron of Bcl-x to regu-
late its alternative splicing pattern. Therefore we also pro-
duced a RNA-map for introns flanking the cassette exon
(Additional file 20B). Since eIF4A3 binds mainly in the
exons, there is very little binding around the flanking
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around the EJC-dependent exons (Additional file 20B).
Taken together, most likely the EJC does not act as other
splicing regulators to regulate alternative splicing by bind-
ing at different positions.
EJC regulates intron retention with shorter introns and
weaker splice sites
In Drosophila, it has been recently shown that the core
EJC components and the peripheral factor Acinus and
RNPS1 can enhance the splicing of neighbouring introns
[29,30]. If the EJC regulate splicing in a similar manner
in mammalian cells, EJC downregulation would cause an
increase in intron retention (IR) events. We therefore
analysed the IR events predicted by MISO and DiffS-
plice. Overall, MISO and DiffSplice identified 134 events
with increased intron retention upon EJC KD (ΔΨ <0.1,
−), and 135 events with decreased intron level upon EJC
KD (ΔΨ >0.1, +) (Additional file 21). We also identified
393 events in the MISO database that did not change in
response to EJC KD. We performed the same analysis as
for cassette exons. The EJC-dependent intron retention
events have significantly shorter introns compared with
control introns, but there is no significant difference be-
tween the EJC-dependent intron retention (+) and spli-
cing (−) (Additional file 22A). We also found that the
EJC-dependent intron retention and splicing events have
significantly weaker splice sites, and the flanking exons
have significantly less ESEs (Additional files 22B,C).
None of the other features were significantly different
from control intron retention events, indicating that the
EJC-regulated intron retention and splicing events have
generally weaker splicing potential, but whether they are
spliced or retained seem to be a more complex decision.
The splicing changes are linked with RNA polymerase II
elongation
The different post-transcriptional steps are tightly coupled
to transcription [46]. For example, changing Pol II elong-
ation rate have an impact on global alternative splicing
patterns [47]. Generally speaking, a slower Pol II elong-
ation rate results in an increase in exon inclusion by ex-
tending the time window for splicing factors to recognise
the weaker alternative splice sites [47,48]. We tested
whether the EJC-dependent splicing events are linked with
changes in transcription. To this end, we treated control
and eIF4A3 KD cells with transcription elongation in-
hibitors: DRB (5,6-dichloro-1-β-D-ribofuranosyl-benz-
imidazole) and Flavopiridol (FP). Both drugs inhibit the
elongation factor P-TEFb [49,50], leading to decreased
Ser2 phosphorylation of the Pol II CTD, and inhibition
of transcription elongation [51,52]. Treatment with both
drugs caused a decrease in Ser2 phosphorylation in con-
trol and knockdown cells, whereas Ser5 phosphorylationwas only affected to a lesser extent (Figure 5A, Additional
file 23A). Furthermore, the decrease in Ser2 phosphoryl-
ation was bigger with increasing concentration of drugs
(Figure 5A). Western blot of Pol II confirmed a reduction
in phosphorylated isoform (upper band) whereas the non-
phosphorylated isoform (lower band) remains the same
(Figure 5A). We also used camptothecin (CPT), which in-
hibits topoisomerase I and creates topoisomerase I-DNA
adducts to block Pol II elongation [53,54]. Treatment with
CPT did not change the phosphorylation level of Pol II
CTD (Figure 5A). To evaluate if the drug treatment was
efficient, we checked the alternative splicing of CHD2 pre-
mRNA, which increase exon skipping with CPT treatment
[55] (Additional file 23C). All drug treatments caused an
increase in exon skipping for CHD2, while eIF4A3 KD
showed no effect (Additional file 23C).
We next monitored the effect of these drugs on several
EJC-dependent splicing events by RT-PCR. For examples,
the constitutive TPCN1 exon 16 increased in exon skip-
ping in eIF4A3 KD samples. Remarkably, the exon skip-
ping level was reduced upon treatment with DRB, FP and
CPT compared to control cells, while the drugs had no
significant effect on the basal splicing pattern in control
siRNA treated cells (Figure 5B). In this case, DRB had the
biggest effect whereas CPT showed less decrease. For the
alternative MRPL3 exon 4, both DRB and FP reduced the
exon skipping level caused by eIF4A3 KD whereas the
effect of CPT is very weak (Figure 5B). In the case of
HNRPDL gene, KD of eIF4A3 caused an increase in exon
inclusion (Figure 5B). Addition of all inhibitors caused a
further increase in exon inclusion not only in control sam-
ples, but also in eIF4A3 KD samples (Figure 5B). This
increase in exon inclusion in control samples with elong-
ation inhibitors has been shown before for HNRPDL [47],
confirming that the splicing changes are due to a change
in Pol II elongation. Therefore, several EJC-dependent
splicing changes are linked with transcription elongation
and Pol II phosphorylation.
To further confirm that the effect of EJC-dependent
splicing changes are linked with transcription elongation
rather than due to unspecific effects, we examined the in
situ transcription rate of candidate genes in response to
EJC KD using Padgett’s protocol [56]. In this procedure
DRB is used to reversely block gene transcription
in vivo, and after its removal, RT-qPCR was performed
to assess the appearance of newly synthesised pre-
mRNA. Two sets of primers corresponding to the begin-
ning and the end of the gene were used, and the differ-
ences in time between the recoveries of expressions
should indicate the relative speed of Pol II transcription
elongation [56]. As expected, the positive control gene,
ITPR1, showed an increase in pre-mRNA of exon 1 early
after DRB removal (10 min), whereas exon 5, which is
133 Kb away, showed an increase much later (50 min)
Figure 5 EJC-dependent alternative splicing is linked with transcription. (A) Western blot of control and eIF4A3 KD cells treated with
different concentration of transcription elongation inhibitors (DRB, FP and CPT) for 16 h. GAPDH is used as a control. (B) RT-PCR of splicing patterns of
representative exons in cells treated with different inhibitors. The quantification of triplicate experiments are shown below as mean ± SD. *P <0.05;
**P <0.01; ***P <0.001, one-way ANOVA.
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[56]. In eIF4A3 and Y14 KD samples, the amount of
pre-mRNAs of exon1 is higher after DRB removal,
which could be due to an increase in Pol II speed or
initiation. However, the similar amount of pre-mRNA
accumulate at intron-exon5 argue for a change in tran-
scription speed (Additional file 24). We also tested one
of our candidate genes, GLRX3 (Additional file 24). The
exon 2 showed a recovery in 20 min in control cells, but
only 10 min in eIF4A3 KD cells and even faster in Y14
KD cells, indicating an increase in transcription rate
(Additional file 24). Furthermore, the recovery of exon 10
is around 30 min in control cells (10 min lag time), but
faster (5 min lag time) in eIF4A3 KD cells (Additional
file 24). Therefore, the reduced EJC level seems to increase
Pol II transcription rate in some EJC-dependent genes,
further demonstrating a link between some EJC-dependent
events and Pol II transcription.Discussion and conclusions
Here, we present evidence that the EJC core proteins can
affect a large set of alternative splicing changes in mam-
malian cells. Several studies before have indicated that
the EJC protein can regulate splicing in different species
[27-29,31,32]. However, these studies only focused on a
specific set of candidate genes. To what extend the modula-
tion of the expression of EJC components effect on alterna-
tive splicing holds true on a genomic scale, and whether
the EJC is directly involved in regulating alternative splicing
remains largely unknown. We analysed the transcriptome
of human cells in which the EJC core proteins have been
downregulated to study the alternative splicing changes re-
lated to EJC proteins. The reduction of EJC caused large
numbers of alternative splicing changes. Different types of
alternative splicing patterns were affected, with a majority
of the cassette exons excluded in EJC KD. Interestingly, our
study also reveals that the EJC KD affected the recognition
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normal growth conditions. Therefore, the EJC has a broad
impact on splicing by contributing to the recognition of nu-
merous exons under normal splicing conditions.
Using different computational tools combined with
direct measurement of specific splicing isoforms, we dis-
covered hundreds of splicing events that were similarly
affected by the independent KD of three EJC core com-
ponents. The EJC could differentially affect the stability
of splicing isoforms via the coupling between alternative
splicing and NMD (AS-NMD). However, this is not al-
ways the case because EJC KD did not influence the
decay rate of the EJC-dependent spliced mRNAs that we
have tested. We also investigated different ways in which
EJC could regulate splicing more directly. An obvious
explanation would be that these downregulations some-
how affect the expression of one or several splicing fac-
tors, which in turn would affect a large number of
splicing events. This cannot be completely excluded but
our analysis of the expression of numerous splicing reg-
ulators did not detect candidates whose expression was
affected by all three KDs independently. Another pos-
sibility would be that the EJC proteins bind specific pre-
mRNAs and interfere with their splicing as previously
observed for Bcl-x gene, which depends on eIF4A3 and
Y14 as well as auxiliary splicing factors of Acinus,
RNPS1 and SAP18 [32]. However, among all the splicing
events affected by the individual EJC core components,
a significant proportion depends on assembled EJC core.
This is supported by the fact that overexpressing a mu-
tant eIF4A3 that is unable to form the EJC core does not
restore most of the EJC-dependent splicing events.
So far, pre-mRNA splicing is the only known process
able to assemble the EJC core. Thus, how does a fully as-
sembled EJC regulate alternative splicing, given that it is
deposited and assembled after the splicing decision has
been made [9,10,57]? The vast majority of mammalian
pre-mRNAs contains multiple introns. Once assembled
onto an exonic junction, the EJC and its associated fac-
tors could serve as a splicing regulator in the recognition
of neighbouring splice sites, and in turn modulate the
splicing pattern. In fact, recent studies in Drosophila
have shown that the splicing of some specific weak in-
trons is dependent on EJC components [29,30]. For ex-
ample, splicing of intron 4 of the piwi transcript requires
the flanking exon junctions and EJC core components as
well as peripheral factors RNPS1 and Acinus [29,30].
Even if we cannot exclude the possibility that this at-
tractive model is responsible for some particular splicing
events in mammalian cells, several data argue against this
as a general mechanism. First, we downregulated EJC as-
sociated splicing factors such as Acinus and SRSF1, but
none of the EJC-dependent splicing events depended on
these factors. Second, Crabb and colleagues have shownthat EJC deposition did not affect subsequent splicing kin-
etics in a reporter with two introns [58]. We also found
that minigene vectors from EJC-regulated splicing events
showed no difference in splicing with or without a pre-
deposition of EJC (data not shown). Third, if the EJC acts
as a classical splicing regulator such as Fox2 or Nova, then
it should regulate alternative splicing in a positional-
dependent manner [59], which can be visualised through a
RNA-map [60]. However, RNA-map of eIF4A3 did not
show significant changes in binding positions for the EJC-
dependent inclusion and skipping events. Moreover, ana-
lysis of enhancers and silencer did not find any significant
differences between the EJC-dependent inclusion and
skipping exons, indicating that the EJC does not globally
regulate alternative splicing as a classic splicing factor.
Fourth, if the EJC deposition is required for the splicing of
neighbouring introns as in Drosophila, EJC KD should
cause more intron retention. However, there is a similar
number of increase or decrease in intron retention in EJC
KD cells, as described in Drosophila [29]. In addition, the
EJC-dependent intron splicing events did not show spe-
cific characteristics compared with the EJC-dependent in-
tron retention events.
The EJC plays a central role in the post-splicing life of
mRNAs. Recently, EJC and SR proteins have been shown
to participate in the formation of higher order mRNP parti-
cles and to contribute to the compaction of processed
mRNAs [8]. It has become more and more clear that the
packaging of pre-mRNAs and mRNAs can influence dif-
ferent steps of mRNA processing as well as transcription
[1,3]. In yeast, connections between transcription and
mRNA packaging has been clearly established, and its im-
portance for quality control of mRNP has been revealed
[61]. In mammals, coupling between RNA pol II transcrip-
tion and pre-mRNA processing has also been established,
and transcription has a clear impact on alternative splicing
[3,62]. In this context, we tested whether some splicing
events affected by EJC core downregulation could be
coupled to transcription. We employed three different in-
hibitors of RNA pol II elongation (DRB, FP and CPT) and
we observed that inhibition of RNA pol II elongation
could rescue most of the EJC-dependent splicing changes.
Indeed, even though the effect of CPT is variable, both
DRB and FP consistently rescued the EJC-dependent spli-
cing changes. Furthermore, by measuring the in situ tran-
scription rate of specific genes, we found that Pol II
transcription accelerates when the EJC proteins amount
was reduced.
Two models have been proposed to explain how tran-
scription can influence splicing: the ‘recruitment model’
and the ‘kinetic model’ [48,62]. In the kinetic model, vari-
ation of elongation rate controls the accessibility of compet-
ing splice sites in nascent RNA. A slower elongation would
increase the time for splice site recognition or for binding
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variation in RNA pol II progression can favour the inclu-
sion or the skipping of alternative exons while a faster
elongation could reversely modulate these choices. We
found that more exons were being kipped when EJC pro-
teins were downregulated compared with exon inclusion,
and that some previously considered as constitutive exons
became excluded. By slowing down the transcription elong-
ation rate, there is more time to recognise the EJC-
dependent cassette exons, and to rescue exon skipping
caused by EJC depletion. We also found that the EJC-
dependent alternative exons generally have longer flanking
introns, and this would allow more time for the alternative
exons to be recognised by splicing enhancer or silencer to
make the splicing decision before the downstream exon is
transcribed. However, the EJC-dependent splicing events
are not secondary effects caused by general changes in
transcription rate, since not every exon regulated by tran-
scription was affected by EJC KD. One example is the
CHD2 gene. The splicing changed significantly in response
to transcription elongation inhibitors, but EJC KD did not
show any effect. We also compared the EJC-dependent
splicing events with the list of splicing changes in DRB and
CPT treatment [47], and less than 15% of transcription-
dependent splicing changes overlapped with the EJC-
dependent events. We also found that the EJC-dependent
intron retention events have significantly shorter exons
with weaker splice sites. It has been shown recently that, in
general, intron retention events were associated with in-
creased GC content, reduced length and weaker 5′ and 3′
splice sites, and this was linked with localised stalling of Pol
II and reduced availability of spliceosomes components
[63]. For the EJC-dependent intron splicing events, the in-
creased transcription elongation rate in EJC KD would
mean less time between the 5′ and 3′ splice site re-
cognition, and would favour intron retention. For the
EJC-dependent intron retention events, the increased
elongation rate would result in less Pol II pausing over
retained introns and increase the splicing of these introns.
Taken together, our data reveal that the EJC partici-
pates in multiple alternative splicing events. At this
stage, we believe that direct and indirect mechanisms
could be responsible for this function of the EJC. The
analysis of specific splicing events will certainly allow
molecular links between the EJC and splicing regulation
to be established. Interestingly, this study brings to light
a potential connection between pre-mRNA synthesis
and the EJC, suggesting that mRNP packaging may also
look back on co-transcriptional processing in mammals.
Materials and methods
Antibodies and plasmids
Rabbit polyclonal anti-eIF4A3, anti-Y14 and anti-MLN51
are gifts from C. Tomasetto. Mouse monoclonal anti-eIF4A3 (3 F1) is a gift from G. Dreyfuss. Rabbit polyclonal
anti-Upf1 and anti-Pol II (N20) are from Santa Cruz.
Rabbit polyclonal anti-SRSF1, anti-SRSF2 and anti-SRSF7
are gifts from J. Stévenin. Rabbit polyclonal anti-Magoh is
a gift from E. Izaurralde. Rabbit anti-FLAG is from Sigma.
Rat monoclonal anti-S2P and anti-S5P are gifts from X.
Darzacq. Mouse monoclonal anti-Pol II (Pol3/3) is a gift
from O. Bensaude.
The original p3xFLAG-CMV-eIF4A3 was a gift from
M. Moore. p3XFLAG-CMV-eIF4A3WT (siRNA-resistant)
was created by site-directed mutagenesis (Invitrogen) for
regions targeted by siRNA eIF4A3. The following primers




eIF4A3 that does not form EJC (D401KE402R) was gene-
rated from the p3xFLAG-CMV-eIF4A3WT with the fol-




Cell culture and transfections
HeLa cells were maintained in DMEM (GIBCO) with
10% FCS (Life Technologies) and penicillin/streptomycin
(Life Technologies). For siRNA knockdown, cells were
transfected with 10 nM of siRNA using RNAiMax (Invi-
trogen) according to manufacturer’s protocol. Cells were
harvested 48 h later. The following siRNA duplexes








AG-3′. For co-transfection of siRNA and plasmids, Lipo-
fection 2000 (Invitrogen) was used. A total of 10 nM of
siRNA was mixed together with 1 ug of p3xFLAG-CMV-
eIF4A3WT or with 3 ug of p3xFLAG-CMV-eIF4A3Mut
to obtain similar level of expression. Cells were collected
48 h after. For inhibition of Pol II elongation, cells were
transfected with 10 nM siRNA for 30 h before adding
DMSO (Sigma), 75 μM DRB (Sigma), 250 nM FP (Sigma)
or 15 μM CPT (Sigma) for further 16 h.
mRNA-seq and data analysis
For mRNA-seq, polyA+ mRNAs were extracted from
HeLa cells treated with siRNA against GFP, eIF4A3, Y14,
MLN51 and Upf1 using Illumina TruSeq RNA sample
preparation kit (Illumina) according to manufacturer’s
protocol. The fragmented mRNAs were sequenced using
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Mapping of reads to the human genome
Raw reads that do not pass the Illumina quality filter were
first discarded. The remaining mRNA-seq reads were
mapped to the human genome (hg19) using TopHat
v.2.08 [64]. Ensembl65 annotations were provided to
TopHat (−G option). Alignments with reads that matches
multiple positions on the genome were removed.
Analysis of differential gene expression
From the mapped reads and the GTF annotation files
(Ensembl65), we counted the number of reads for each
gene using htseq-count [65]. To normalise the read counts
and perform differential gene expression analysis, we used
the DESeq package [33]. There were 24,978 genes with
read counts. We chose a read coverage of 10 as a thresh-
old in any of the KD conditions to ensure transcripts are
reasonably expressed. The coverage was computed as the
read length (51 bases) multiplied by the number of reads
divided by the transcript length. This filter selected 10,881
genes. Then we filtered transcripts with significant expres-
sion changes using the cutoff of adjusted P value 0.05.
Identification of differential exon usage
We use two different software to perform differential
exon usage analysis: MISO [34] and DiffSplice [35].
MISO
MISO estimates isoform expression (Ψ values, for ‘Percent
Spliced Isoform’) and differential isoform expression for
RNA-Seq data. We used the exon-centric analysis, which
perform expression estimates at the alternative splicing
event level. It provides confidence intervals for expression
estimates and quantitative measures of differential expres-
sion (‘Bayes factors’). Since MISO does not handle repli-
cate experiments, the program was run independently for
each replicate (that is, compare GFPa vs 4A3a and GFPb
vs 4A3b). The parameters used to filter differentially
expressed events were: ΔΨ >0.1, bayes-factor >5, number
of skipping reads >10, number of inclusion reads >10, sum
of inclusion and skipping reads >20.
DiffSplice
DiffSplice identifies alternative splicing modules (ASMs)
that correspond to genomic regions where alternative
transcripts diverge. The ASMs are detected from a splice
graph, which is built from RNA-seq reads. The method
handles replicate experiments and does not depend on
gene annotations, allowing the discovery of novel alterna-
tive splicing events. The parameters used for the splice
graph construction were 5 for thresh_average_read_covera-
ge_exon and 10 for thresh_average_read_coverage_intron.The thresholds for splice junction filtering (thresh_
junction_filter_max_read_support, thresh_junction_filter_
mean_read_support) were increased to 5 and thresh_junc-
tion_filter_num_samples_presence was set to 1. For the dif-
ferential tests, the minimum value square root of JSD for
significant differential transcription (thresh_sqrtJSD) was
set to 0.1 and the false discovery rate was set to 1.
Analysis of cassette exons with splicing changes
We focused on cassette exon events. We took the union
of events with significant splicing change identified with
MISO or DiffSplice with the threshold of ΔΨ >0.1. Be-
cause DiffSplice only returned the end position of the up-
stream exon and the start position of the downstream
exon, we retrieved the genomic coordinates of the up-
stream, cassette and downstream exon of the splicing event
based on Ensembl65 annotations. We classified splicing
events into two categories based on the direction of the
change: events showing an increase in exon inclusion in
EJC KD (ΔΨ < −0.1, −, 160 exons) and events showing an
increase in exon skipping in EJC KD (ΔΨ >0.1, +, 291
exons). Furthermore, we classified events of the + category
identified by DiffSplice into two categories: events corre-
sponding to annotated alternative exons (ALT, 233 exons)
and events corresponding to constitutive exons (exons
having no annotation in the genome as alternative exons,
CON, 58 exons).
As a control, we used two sets of exons: alternative
exons from the MISO database that were not affected by
eIF4A3 KD (Ctr, 991 exons) and constitutive exons from
the genome (Ctr CON, 811 exons). Those exons were
selected among expressed genes (read coverage more
than 10). For the Ctr category, we filtered events with a
splicing change less than 0.03 and with estimates of Ψ
values included in (0.1;0.9) as predicted by MISO. For
the Ctr CON category, we selected three successive con-
stitutive exons based on Ensembl65 annotations, exclud-
ing the first and last exon of transcripts and allowing at
most one triplet per gene.
Once exons with splicing changes have been identified,
we look at possible correlations with different features.
Computational analyses were performed using custom
scripts in Python and R.
Analysis of intron retention with splicing changes
We took the union of events with significant splicing
change identified with MISO or DiffSplice with the
threshold of |ΔΨ| >0.1. We retrieved the genomic coor-
dinates of the exons flanking the intron retention events
and the exons further upstream or downstream to define
the flanking intron. We classified splicing events into
two categories based on the direction of the change:
events showing an increase in exon retention in EJC KD
(ΔΨ <0.1, −, 134 exons) and events showing a decrease
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a control, we used intron retention events from the
MISO database that were not affected by EJC KD with
criteria as above (Ctr, 393 exons). Again, computational
analyses were performed using custom scripts in Python
and R.
5′ and 3′ splice sites strength
To compute a score for the 5′ and 3′ splice sites, we
used the maximum entropy models for splice sites
(MaxEntScan, [66]). The 5′ss scoring uses a 9-mer se-
quence (the last 3 nt of the exon and the first 6 nt of the
downstream intron), while the 3′ss scoring uses a 23-
mer sequence (the last 20 nt of the upstream intron and
the first 3 nt of the exon).
Analysis of splicing regulatory elements
For exonic splicing enhancers (ESE), we use the predic-
tions of RESCUE-ESE [67], which identified 238 candidate
hexamers in human genes. For exonic splicing silencers
(ESS), we use the predictions of the fluorescence-activated
screen for exonic splicing silencers (FAS-ESS, [68]), which
identified 176 hexamers that occurred repeatedly in the
screen. For intronic splicing enhancers (ISE), we use the
predictions of the fluorescence-activated screen for in-
tronic splicing enhancers (FAS-ISE, [69]), which identified
199 hexamers that occurred repeatedly in the screen. For
intronic splicing silencers (ISS), we use the predictions of
the fluorescence-activated screen for intronic splicing si-
lencers (FAS-ISS, [70]), which yielded 102 decamers.
The frequency of ESE or ESS in the upstream, cassette
and downstream exon was computed as the number of
ESE or ESS in the exon normalised by the length of the
exon. The frequency of ISE or ISS in the upstream and
downstream intron was computed as the number of ISE
or ISS in the intron divided by the length of the intron.
To calculate the enrichment of each ESE, z score was
calculated by comparing the frequency of ESE to the fre-
quency of ESE in the same sequence randomised 100
times.
Construction of RNA splicing map with eIF4A3 CLIP data
We plotted RNA splicing maps using the CLIP-seq data
of eIF4A3 [7]. We analysed the CLIP-seq coverage in the
cassette exon and upstream and downstream exon for
the same sets of exons as described previously. We ana-
lysed 100 nt from the exon-intron border. The eIF4A3
CLIP-seq coverage was normalised by mRNA expression
at the position (using the mRNA-seq data for siGFP),
and the number of exons that cover this position. The
normalised coverage was then represented as the frac-
tion of reads at a position over the highest CLIP height
of the analysed region (upstream, cassette and down-
stream exon). The height of CLIP reads at each positionis the sum of all normalised coverage at that position for
each category of exons.
RNA extraction and RT-PCR analysis
Total RNA was extracted from cells using TRI reagent
(Ambion) according to manufacturer’s protocol. The RNA
was digested with 2U RNase-free DNase I (Ambion) for
30 min at 37°C before phenol extraction and precipitation.
Reverse transcription was performed using 500 ng RNA
with random primers and RevertAid reverse transcriptase
(Fermentas) according to manufacturer’s protocol. For
radioactive PCR analysis of alternative splicing, primer sets
were designed across the constitutive exons. The list of
primer sequences is shown in Additional file 8. To radio-
actively label the primers, 2.5 μM of each primer were in-
cubated with 32P-γ-ATP and PNK (Fermentas) at 37°C for
30 min before purifying through a G6 column (Biorad).
PCR reaction was performed with DreamTaq polymerase
(Fermentas) using 1 μl of hot primers and 1 μl of cDNA
for 25 cycles at 60°C annealing temperature. The 2x RNA
Loading Dye (Ambion) were added to the PCR products,
and were denatured at 95°C before resolving on the 8%
denaturing polyacrylamide gel. Results were quantified
with the Typhoon Imager (GE healthcare) and Image J
software.
Quantitative real-time PCR
Real-time PCR was performed using SYBR Select Master
Mix (Life Technologies) on LightCycler (Roch). Primers
for qPCR can be found in Additional file 14. The relatively
amount of each RNA was calculated by the threshold cycle
for each PCR product (Ct) in control and knockdown
conditions, and compared with the house-keeping gene
GAPDH (Glyceraldehyde-3-phosphate dehydrogenase).
Immunoprecipitation and western blot analysis
HeLa cells were transfected with empty vectors or
FLAG-tagged eIF4A3 for 48 h before collection. The
cells were lysed in PXL buffer (1xPBS, 0.1% SDS, 0.5%
NP-40, 0.5% Na deoxycholate) supplemented with prote-
ase inhibitor (Calbiochem), and incubated with RNAse
A (Fermentas) and Turbo DNase (Ambion) for 10 min
at 37°C. After centrifugation, the cell lysates were incu-
bated with anit-FLAG beads (Sigma) for 2 h. After wash-
ing three times with 10 mM Tris–HCl, pH7.5, 150 mM
NaCl, 2.5 mM MgCl2, 1% NP-40, the proteins were
eluted by adding 1× elution buffer and heating at 50°C.
The eluate was subjected to western blot analysis, and
1/15th of input was used.
For western blot analysis, cells were lysed in PXL buf-
fer as described above. Equal amount of total protein
were used, and separated by 6%, 10% or 12% of SDS-
PAGE depending on the protein probed. The proteins
were transferred to nitrocellulose membrane (Amersham),
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with primary antibody (1:1,000 dilution except for Pol3/3,
1:500 dilution) for 2 h at room temperature before adding
peroxidase-conjugated secondary antibodies (Thermo
Scientific) for 1 h. The antibodies were detected by
Femto ELC (Thermo Scientific) on a LAS400 machine
(GE healthcare).
RNA decay assay
HeLa cells were transfected with siRNA against GFP or
eIF4A3 for 48 h. Cells were treated with 5 μg/ml of Acti-
nomycin D (Sigma) and collected at various time points
after the treatment. The total RNA was extracted using
TRI reagent (Invitrogen), and RT-qPCR was performed
as described above. GAPDH was used as a control gene.
The relatively amount of mRNA in each sample was calcu-
lating by normalizing again GAPDH, and shown as a frac-
tion of the mRNA level before Actinomycin D treatment.
RNAPII transcription rate assay
The rates of RNA Pol II transcription were measured as
previously described [56]. Briefly, HeLa cells were trans-
fected with 10 nM siRNA against GFP, eIF4A3 or Y14
for 48 h. The cells were treated with 100 μM DRB in
culture media for 3 h before washed with PBS and incu-
bated with fresh media. Cells were collected at different
time points after DRB removal and lysed in TRI reagent
(Invitrogen) to extract total RNA. One microgram of
total RNA was amplified using RevertAid reverse tran-
scriptase (Fermentas), and the cDNA was used for real-
time qPCR. GAPDH was used as a control gene (primers
cross exon junction borders to detect mRNA). Each primer
set was designed to across the exon-intron junction to de-
tect the newly amplified pre-mRNA (Additional file 14).
The relative amount of pre-mRNA at each time point was
calculated by normalising against the GAPDH gene and
shown as a fraction of the amount of pre-mRNA when
cells were not treated with DRB.
Data availability
High throughput sequencing data generated in this study
has been submitted to NCBI’s Gene Expression Omnibus
with the accession number GSE63091.
Additional files
Additional file 1: mRNA-seq experiments in HeLa cells with EJC and
UPf1 KD. (A) Western blot of the KD efficiency for samples used in
mRNA-seq experiments. (B) qPCR evaluation of the KD efficiency for
samples used in mRNA-seq experiments. Data are shown as mean ± SD
of triplicate experiments. ***P <0.001, student t-test. (C) Pie-chart showing
the percentage of uniquely mapped mRNA-seq reads for the different
conditions. (D) Log plots showing the correlation of the number of
uniquely mapped reads per genes between the two replicated mRNA-seq
experiments for each KD condition. Pearson’s correlation coefficient (r2) foreach comparison is indicated. (E) Log plots showing the correlation of the
gene expression fold changes among the different KD conditions. Pearson’s
correlation coefficient (r2) for each comparison is indicated.
Additional file 2: Mapping information of mRNA-seq experiments.
Additional file 3: List of genes with significant expression changes
in any of the KD conditions.
Additional file 4: Gene expression changes in EJC and Upf1 KD
HeLa cells. (A) Venn diagrams showing the overlap of genes with
significant change in gene expression (padj <0.05) in each direction
between eIF4A3, Y14 and MLN51 KD. (B) Venn diagrams showing the
number of genes significantly changed in each direction for union of EJC
KD and Upf1 KD. (C) RT-qPCR validation of predicted gene expression
changes in eIF4A3 KD. The first five genes were predicted to be upregulated,
and the next five genes were predicted to be downregulated in eIF4A3 KD.
The last five genes were predicted to have no change in eIF4A3 KD. Data
are shown as mean ± SD of triplicate experiments. **P <0.01; ***P <0.001,
student t-test.
Additional file 5: Overlap of predicted alternative cassette exons
for MISO and DiffSplice. (A) Venn diagrams showing the overlap of
significant splicing events identified with MISO between the two
replicates of the eIF4A3, Y14 and MLN51 KD conditions, using a threshold
of 0.1 for ΔΨ. (B,C) Venn diagrams showing the overlap of significant
splicing events identified with MISO (B) or DiffSplice (C) between the
eIF4A3, Y14 and MLN51 KD conditions (left panel) and between the EJC
(union of events identified with eIF4A3, Y14 and MLN51) and UPF1 KD
conditions (right panel), using a threshold of 0.1 for ΔΨ. The rates of
RT-PCR validation for each category are shown.
Additional file 6: Summary of alternative splicing events identified
by MISO.
Additional file 7: Summary of alternative splicing events identified
by DiffSplice.
Additional file 8: RT-PCR primers for validation of alternative splicing.
Additional file 9: Validation of predicted cassette exons in EJC KDs.
(A,B) RT-PCR validation of cassette exon events predicted by MISO or
DiffSplice, in different EJC core protein, Acinus, SR proteins and Upf1 KD
cells. Both alternative (A) and constitutive (B) exons were chosen. The
quantification of triplicate experiments are shown below as mean ± SD.
*P <0.05; **P <0.01; ***P <0.001, one-way ANOVA.
Additional file 10: List of alternative cassette splicing events
identified by MISO and DiffSplice.
Additional file 11: Validation of predicted alternative splicing
changes. (A-C) RT-PCR validation of A5SS (A), A3SS (B) and IR (C) events
predicted by MISO. (D) RT-PCR validation of cassette exons that are changed
in Upf1 KD. The quantification of triplicate experiments are shown below as
mean ± SD. *P <0.05; **P <0.01; ***P <0.001, one-way ANOVA.
Additional file 12: Alternative splicing patterns in eIF4A3 rescue
experiments. RT-PCR validation of candidate alternative splicing events
in control and eIF4A3 KD cells overexpressed with siRNA-resistant eIF4A3
(WT) or a mutant that does not form EJC (Mut). The quantification of triplicate
experiments are shown below as mean ± SD. *P <0.05; **P <0.01; ***P <0.001,
one-way ANOVA.
Additional file 13: EJC KD does not affect mRNA decay. (A) RT-PCR
of candidate alternative splicing events in control and NMD factor SMG6
KD cells, in parallel with eIF4A3 and UPF1 KD. The quantification of triplicate
experiments are shown below as mean ± SD. ***P <0.001, one-way ANOVA.
(B,C) mRNA decay assay for different genes in control, eIF4A3 and Upf1 KD
cells. A positive control (MYC) and a negative control (DNM2) are shown in
(B), and the EJC-dependent alternative splicing genes are shown in (C). For
alternative splicing genes, two sets of primers were used to amplify either all
isoforms or inclusion-specific isoforms, and the schematic diagram is shown
above. Data are shown as mean ± SEM of four independent experiments.
Additional file 14: List of qPCR primers.
Additional file 15: Expression changes of splicing factors.
Additional file 16: Gene expression changes of other splicing
factors. (A) qPCR of gene expression level of SR proteins, ASAP proteins
and other splicing factors in eIF4A3, Y14, MLN51 and Upf1 KD conditions.
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***P <0.001, one-way ANOVA. (B) Western blot showing the level of SRSF1,
SRSF2 and SRSF7 proteins in EJC protein KD cells. GAPDH is used as
a control.
Additional file 17: Correlation between EJC-dependent transcript
level and intron length. (A-C) Lot plots showing the correlation
between the gene expression fold change and the maximum intron
length in the corresponding transcript for KD of eIF4A3 (A), Y14 (B) and
MLN51 (C). All the genes have a read coverage of more than 10.
Additional file 18: Characteristic of EJC-dependent cassette exons.
(A-F) Box plot comparing EJC-dependent exon inclusion (+), exon
skipping (−) and control exons that have no splicing changes (Ctr).
(G-L) Box plot comparing EJC-dependent constitutive exon inclusion
(Con) with control constitutive exons (Ctr Con). The P value is calculated
with Mann–Whitney-Wilcoxon Test, and is indicated. (A, G) Box plot of
the sum of 5′ and 3′ splice site scores of the upstream and downstream
introns. (B,H) Box plot of the exon length for the upstream exon,
cassette exon and downstream exon. (C,I) Box plot of the frequency of
ESE for upstream exon, cassette exon and downstream exon. (D,J) Box
plot of the frequency of ESS for upstream exon, cassette exon and
downstream exon. (E,K) Box plot of the frequency of ISS within the
upstream and downstream introns. (F,L) Box plot of the exon length for
upstream exon, cassette exon and downstream exon.
Additional file 19: List of ESE hexamer enriched in upstream
constitutive, alternative and downstream constitutive exons.
Additional file 20: RNA map of EJC-dependent splicing events. (A)
RNA splicing map showing the binding of eIF4A3 in the upstream exon,
cassette exon and downstream exon, 100 nt from exon-intron boarders.
EJC-dependent alternative exon inclusion is shown as red, constitutive
exon inclusion is shown as purple. The control alternative exons (above)
and constitutive exons (below) that does not change in EJC KD are
shown as grey. The CLIP reads were normalised to mRNA expression level
and exon length, and the height of CLIP reads at a position is the sum of
all normalised CLIP reads at that position for each category of exons. (B)
RNA splicing map showing the binding of eIF4A3 in the flanking introns
around the cassette exons, 150 nt from exon-intron boarders.
Additional file 21: List of intron retention events changed
identified by MISO and DiffSplice.
Additional file 22: Characterisation of EJC-dependent intron
retention events. Box plot comparing EJC-dependent intron retention
(+), intron splicing (−) with control exons that have no splicing changes
(Ctr). (A) Boxplot of intron length for alternative intron and the flanking
introns. (B) Boxplot of sum of 5′SS and 3′SS score for alternative and
flanking introns. (C) Boxplot of ESE frequency for exons around the
alternative and flanking introns.
Additional file 23: RNA Pol II elongation is linked with EJC-dependent
splicing. (A) Western blot of control and eIF4A3 KD cells treated with Pol II
elongation inhibitor. DRB, 75 μM; FP, 250 nM; CPT, 15 μM. GAPDH is used as a
control. (B) RT-PCR of splicing pattern of a representative gene HERC4 exon 25
treated with increasing amount of FP. (C) RT-PCR of alternative splicing
pattern in control and eIF4A3 KD cells with different elongation inhibitors.
The quantification of triplicate experiments are shown below as mean ± SD.
*P <0.05; **P <0.01; ***P <0.001, one-way ANOVA.
Additional file 24: RNA Pol II processivity assay in control and
eIF4A3 and Y14 KD cells. The amount of pre-mRNA after transcription
inhibitor DRB removal at different times was shown for control gene ITPR1
(A) and an EJC-dependent cassette exon GLRX3 (B). The gene structure is
shown above each graph, and arrows indicating the exon-intron junctions
analysed. Data are shown as mean ± SEM for four different experiments.
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